Purple Biotech Stock Market Value
| PPBT Stock | USD 0.62 0.12 16.22% |
| Symbol | Purple |
Purple Biotech Price To Book Ratio
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Purple Biotech. If investors know Purple will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Purple Biotech listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.79) | Return On Assets (0.28) | Return On Equity (0.49) |
The market value of Purple Biotech is measured differently than its book value, which is the value of Purple that is recorded on the company's balance sheet. Investors also form their own opinion of Purple Biotech's value that differs from its market value or its book value, called intrinsic value, which is Purple Biotech's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Purple Biotech's market value can be influenced by many factors that don't directly affect Purple Biotech's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Purple Biotech's value and its price as these two are different measures arrived at by different means. Investors typically determine if Purple Biotech is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Purple Biotech's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Purple Biotech 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Purple Biotech's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Purple Biotech.
| 05/06/2024 |
| 06/05/2024 |
If you would invest 0.00 in Purple Biotech on May 6, 2024 and sell it all today you would earn a total of 0.00 from holding Purple Biotech or generate 0.0% return on investment in Purple Biotech over 30 days. Purple Biotech is related to or competes with Akari Therapeutics, Nutriband, Aileron Therapeutics, SAB Biotherapeutics, Vaccinex, GeoVax Labs, and Corvus Pharmaceuticals. Purple Biotech Ltd., a clinical-stage company, focuses on developing therapies to overcome tumor immune evasion and drug... More
Purple Biotech Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Purple Biotech's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Purple Biotech upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.05) | |||
| Maximum Drawdown | 39.15 | |||
| Value At Risk | (9.78) | |||
| Potential Upside | 9.84 |
Purple Biotech Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Purple Biotech's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Purple Biotech's standard deviation. In reality, there are many statistical measures that can use Purple Biotech historical prices to predict the future Purple Biotech's volatility.| Risk Adjusted Performance | (0.02) | |||
| Jensen Alpha | (0.37) | |||
| Total Risk Alpha | (0.46) | |||
| Treynor Ratio | (0.69) |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Purple Biotech's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Purple Biotech Backtested Returns
Purple Biotech maintains Sharpe Ratio (i.e., Efficiency) of -0.043, which implies the firm had a -0.043% return per unit of risk over the last 3 months. Purple Biotech exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check Purple Biotech's Risk Adjusted Performance of (0.02), variance of 46.88, and Coefficient Of Variation of (1,950) to confirm the risk estimate we provide. The company holds a Beta of 0.52, which implies possible diversification benefits within a given portfolio. As returns on the market increase, Purple Biotech's returns are expected to increase less than the market. However, during the bear market, the loss of holding Purple Biotech is expected to be smaller as well. At this point, Purple Biotech has a negative expected return of -0.3%. Please make sure to check Purple Biotech's maximum drawdown, accumulation distribution, as well as the relationship between the Accumulation Distribution and price action indicator , to decide if Purple Biotech performance from the past will be repeated at some point in the near future.
Auto-correlation | -0.33 |
Poor reverse predictability
Purple Biotech has poor reverse predictability. Overlapping area represents the amount of predictability between Purple Biotech time series from 6th of May 2024 to 21st of May 2024 and 21st of May 2024 to 5th of June 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Purple Biotech price movement. The serial correlation of -0.33 indicates that nearly 33.0% of current Purple Biotech price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.33 | |
| Spearman Rank Test | 0.26 | |
| Residual Average | 0.0 | |
| Price Variance | 0.01 |
Purple Biotech lagged returns against current returns
Autocorrelation, which is Purple Biotech stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Purple Biotech's stock expected returns. We can calculate the autocorrelation of Purple Biotech returns to help us make a trade decision. For example, suppose you find that Purple Biotech has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Purple Biotech regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Purple Biotech stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Purple Biotech stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Purple Biotech stock over time.
Current vs Lagged Prices |
| Timeline |
Purple Biotech Lagged Returns
When evaluating Purple Biotech's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Purple Biotech stock have on its future price. Purple Biotech autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Purple Biotech autocorrelation shows the relationship between Purple Biotech stock current value and its past values and can show if there is a momentum factor associated with investing in Purple Biotech.
Regressed Prices |
| Timeline |
Pair Trading with Purple Biotech
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Purple Biotech position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Purple Biotech will appreciate offsetting losses from the drop in the long position's value.The ability to find closely correlated positions to Purple Biotech could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Purple Biotech when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Purple Biotech - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Purple Biotech to buy it.
The correlation of Purple Biotech is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Purple Biotech moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Purple Biotech moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Purple Biotech can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for Purple Stock Analysis
When running Purple Biotech's price analysis, check to measure Purple Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Purple Biotech is operating at the current time. Most of Purple Biotech's value examination focuses on studying past and present price action to predict the probability of Purple Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Purple Biotech's price. Additionally, you may evaluate how the addition of Purple Biotech to your portfolios can decrease your overall portfolio volatility.